Emergence of Clinical \i Escherichia coli\i0 Isolates with Decreased Susceptibility to Ceftazimide and Synergistic Effect with Co-Amoxiclav Due to SHV-1 Hyperproduction

E. Miró; M. del Cuerpo; F. Navarro; M. Sabate; B. Mirelis; G. Prats

Emergence of Clinical \i Escherichia coli\i0 Isolates with Decreased Susceptibility to Ceftazimide and Synergistic Effect with Co-Amoxiclav Due to SHV-1 Hyperproduction

E. Miró, M. del Cuerpo, F. Navarro, M. Sabate, B. Mirelis, G. Prats

Departament de Genètica i de Microbiologia

Producció científica: Contribució a revista › Article › Recerca

Idioma original	Anglès
Pàgines (de-a)	535-538
Revista	J. Antimicrobial Chemother.
Volum	42
Número	0
Estat de la publicació	Publicada - 1 de gen. 1998

Altres arxius i enllaços

https://www.scopus.com/pages/publications/0031685290

Com citar-ho

@article{e53bfc102e2b4e2888cf9224fd7f8c1e,

title = "Emergence of Clinical \textbackslash{}i Escherichia coli\textbackslash{}i0 Isolates with Decreased Susceptibility to Ceftazimide and Synergistic Effect with Co-Amoxiclav Due to SHV-1 Hyperproduction",

author = "E. Mir{\'o} and \{del Cuerpo\}, M. and F. Navarro and M. Sabate and B. Mirelis and G. Prats",

year = "1998",

month = jan,

day = "1",

language = "English",

volume = "42",

pages = "535--538",

number = "0",

}

TY - JOUR

T1 - Emergence of Clinical \i Escherichia coli\i0 Isolates with Decreased Susceptibility to Ceftazimide and Synergistic Effect with Co-Amoxiclav Due to SHV-1 Hyperproduction

AU - Miró, E.

AU - del Cuerpo, M.

AU - Navarro, F.

AU - Sabate, M.

AU - Mirelis, B.

AU - Prats, G.

PY - 1998/1/1

Y1 - 1998/1/1

UR - https://www.scopus.com/pages/publications/0031685290

M3 - Article

SN - 0305-7453

VL - 42

SP - 535

EP - 538

JO - J. Antimicrobial Chemother.

JF - J. Antimicrobial Chemother.

IS - 0

ER -